首页> 外文OA文献 >Differences in incidence and co-occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33

【2h】

Differences in incidence and co-occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33

机译：在人乳头瘤病毒大量接种疫苗之前芬兰人群中疫苗和非疫苗人乳头瘤病毒类型的发病率和共同发生率的差异表明HpV33具有竞争优势

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Merikukka, Marko; Kaasila, Marjo; Namujju, Proscovia B.; Palmroth, Johanna; Kirnbauer, Reinhard; Paavonen, Jorma; Surcel, Helja-Marja; Lehtinen, Matti;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Differences in incidence and co-occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33. [J] . Merikukka M, Kaasila M, Namujju PB, International Journal of Cancer =: Journal International du Cancer . 2011,第5期

机译：在人乳头瘤病毒大规模接种之前，芬兰人群中疫苗和非疫苗型人乳头瘤病毒的发病率和共存率存在差异，这表明HPV33具有竞争优势。
2. Correction: Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-na???ˉve women: results from the control arm of a phase II HPV-16/18 vaccine trial,Incidence and duration of type-specific human papillomavirus infection in [J] . BMJ Open . 2016,第9期

机译：更正：高危HPV初生女性中特定类型的人乳头瘤病毒感染的发生率和持续时间：II期HPV-16 / 18疫苗试验的对照组的结果，特定类型的人的发生率和持续时间乳头瘤病毒感染
3. Substantial Decline in Prevalence of Vaccine-Type and Nonvaccine-Type Human Papillomavirus (HPV) in Vaccinated and Unvaccinated Girls 5 Years After Implementing HPV Vaccine in Norway [J] . Feiring Berit, Laake Ida, Christiansen Irene Kraus, The Journal of Infectious Diseases . 2018,第12期

机译：在在挪威实施HPV疫苗后，疫苗型和非Vactic-型人乳头瘤病毒（HPV）的疫苗型和非Vaccine型人乳头瘤病毒（HPV）的大幅下降
4. The synthesis and immunological activity of a lipid-core peptide(LCP)based Human Papillomavirus(HPV)type-16 vaccine [C] . Peter M.Moyle, Colleen Olive, Hsien Sun International Peptide Symposium;European Peptide Symposium . 2005

机译：脂质肽（LCP）人乳头瘤病毒（HPV）型16型疫苗的合成和免疫活性
5. Human papillomavirus: Trends in human papillomavirus rates, vaccine uptake, and factors driving intention to vaccinate. [D] . Wilson, Andrew. 2015

机译：人乳头瘤病毒：人乳头瘤病毒的发生率，疫苗摄入量和驱动疫苗接种意向的趋势。
6. Substantial Decline in Prevalence of Vaccine-Type and Nonvaccine-Type Human Papillomavirus (HPV) in Vaccinated and Unvaccinated Girls 5 Years After Implementing HPV Vaccine in Norway [O] . Berit Feiring, Ida Laake, Irene Kraus Christiansen, -1

机译：在挪威实施HPV疫苗接种5年后接种疫苗和未接种疫苗的女孩中的疫苗型和非疫苗型人乳头瘤病毒（HPV）患病率大幅下降
7. Occurrence of vaccine and non-vaccine human papillomavirus types in adolescent Finnish females 4 years post-vaccination [O] . Palmroth, Johanna, Merikukka, Marko, Paavonen, Jorma, 2012

机译：疫苗接种4年后青少年芬兰女性中疫苗和非疫苗人乳头瘤病毒类型的发生

Differences in incidence and co-occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33

著录项

相似文献

相关主题

期刊订阅